Aschenbeck KA, Hordinsky MK, Kennedy WR, Wendelschafer-Crabb G, Ericson ME, Kavand S et al (2018) Neuromodulatory treatment of recalcitrant plaque psoriasis with onabotulinumtoxinA. J Am Acad Dermatol [internet] 79:1156–1159. https://doi.org/10.1016/j.jaad.2018.07.058

Article  PubMed  Google Scholar 

Becker WJ (2020) Botulinum Toxin in the Treatment of Headache. Toxins (Basel). https://doi.org/10.3390/toxins12120803

Article  PubMed  PubMed Central  Google Scholar 

Borodic GE, Caruso P, Acquadro M, Chick S (2014) Parry-Romberg syndrome vasculopathy and its treatment with botulinum toxin. Ophthalmic Plast Reconstr Surg. https://doi.org/10.1097/IOP.0b013e31828de9c0

Article  PubMed  Google Scholar 

Bumb A, Seifert B, Wetzel S, Agosti R (2013) Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker. Springerplus. https://doi.org/10.1186/2193-1801-2-377

Article  PubMed  PubMed Central  Google Scholar 

Cady R, Turner I, Dexter K, Beach ME, Cady R, Durham P (2014) An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine. Headache 54:269–277. https://doi.org/10.1111/head.12250

Article  PubMed  Google Scholar 

Califf RM (2018) Biomarker definitions and their applications. Exp Biol Med (Maywood). https://doi.org/10.1177/1535370217750088

Article  PubMed  Google Scholar 

Cernuda-Morollón E, Martínez-Camblor P, Ramón C, Larrosa D, Serrano-Pertierra E, Pascual J (2014) CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine. Headache 54:987–995. https://doi.org/10.1111/head.12372

Article  PubMed  Google Scholar 

Cernuda-Morollón E, Ramón C, Martínez-Camblor P, Serrano-Pertierra E, Larrosa D, Pascual J (2015) OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine. Pain 156:820–824. https://doi.org/10.1097/j.pain.0000000000000119

Article  CAS  PubMed  Google Scholar 

Charles A, Nwaobi SE, Goadsby P (2021) Inflammation in migraine…or not…: A critical evaluation of the evidence. Headache 61:1575–1578. https://doi.org/10.1111/head.14224

Article  PubMed  Google Scholar 

CASP Checklists - Critical Appraisal Skills Programme [Internet]. CASP - Critical Appraisal Skills Programme. [cited 2024 Sep 11]. https://casp-uk.net/casp-tools-checklists/

Choi MG, Yeo JH, Kang JW, Chun YS, Lee JK, Kim JC (2019) Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines. Graefes Arch Clin Exp Ophthalmol [internet] 257:331–338. https://doi.org/10.1007/s00417-018-4194-3

Article  CAS  PubMed  Google Scholar 

ClinicalTrials.gov [Internet]. National Library of Medicine (US). Identifier NCT01071096. Calcitonin Gene-related Peptide Levels in Chronic Migraine (Cady, Roger, M.D); 2003-02-12. [cited 2023 Oct 25]. https://clinicaltrials.gov/study/NCT01071096

ClinicalTrials.gov [Internet]. National Library of Medicine (US). Identifier NCT02037425. Exploratory Study of the Natural History, Clinical Outcomes, and Neuronal Endplate Changes in Subjects Reporting Short Duration vs. Long Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine (Cady, Roger, M.D); 2016-08-11. [cited 2023 Oct 25]. https://clinicaltrials.gov/study/NCT02037425?tab=history&a=1

Corrigan F, Mander KA, Leonard AV, Vink R (2016) Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation. J Neuroinflam 13:264. https://doi.org/10.1186/s12974-016-0738-9

Article  CAS  Google Scholar 

Cutrer F, Pittelkow M (2006) Cephalalgic alopecia areata: a syndrome of neuralgiform head pain and hair loss responsive to botulinum A toxin injection. Cephalalgia Intern J Headache 26:747–751. https://doi.org/10.1111/j.1468-2982.2006.01098.x

Article  CAS  Google Scholar 

Cutrer FM, Sandroni P, Wendelschafer-Crabb G (2010) Botulinum toxin treatment of cephalalgia alopecia increases substance P and calcitonin gene-related peptide-containing cutaneous nerves in scalp. Cephalalgia 30:1000–1006. https://doi.org/10.1111/j.1468-2982.2009.01987.x

Article  CAS  PubMed  Google Scholar 

da Silva LB, Kulas D, Karshenas A, Cairns BE, Bach FW, Arendt-Nielsen L et al (2014) Time course analysis of the effects of botulinum neurotoxin type A on pain and vasomotor responses evoked by glutamate injection into human temporalis muscles. Toxins (Basel). https://doi.org/10.3390/toxins6020592

Article  PubMed  PubMed Central  Google Scholar 

de Tommaso M, Delussi M, Ricci K, Montemurno A, Carbone I, Vecchio E (2016) Effects of onabotulintoxina on habituation of laser evoked responses in chronic migraine. Toxins. https://doi.org/10.3390/toxins8060163

Article  PubMed  PubMed Central  Google Scholar 

Dini E, Mazzucchi S, De Luca C, Cafalli M, Chico L, Lo Gerfo A et al (2019) Plasma levels of oxidative stress markers, before and after BoNT/A treatment, in chronic migraine. Toxins (Basel). https://doi.org/10.3390/toxins11100608

Article  PubMed  PubMed Central  Google Scholar 

Domínguez C, Vieites-Prado A, Pérez-Mato M, Sobrino T, Rodríguez-Osorio X, López A et al (2018) CGRP and PTX3 as predictors of efficacy of onabotulinumtoxin Type A in chronic migraine: an observational study. Headache. https://doi.org/10.1111/head.13211

Article  PubMed  Google Scholar 

Domínguez Vivero C, Leira Y, Saavedra Piñeiro M, Rodríguez-Osorio X, Ramos-Cabrer P, Villalba Martín C et al (2020) Iron deposits in periaqueductal gray matter are associated with poor response to onabotulinumtoxinA in chronic migraine. Toxins (Basel). https://doi.org/10.3390/toxins12080479

Article  PubMed  PubMed Central  Google Scholar 

Fang X-X, Zhai M-N, Zhu M, He C, Wang H, Wang J et al (2023) Inflammation in pathogenesis of chronic pain: Foe and friend. Mol Pain. https://doi.org/10.1177/17448069231178176

Article  PubMed  PubMed Central  Google Scholar 

FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource [Internet]. Silver Spring (MD): Food and Drug Administration (US); 2016. http://www.ncbi.nlm.nih.gov/books/NBK326791/

Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neur 14:162–173. https://doi.org/10.1016/S1474-4422(14)70251-0

Article  CAS  Google Scholar 

Finzi E, Rosenthal NE (2014) Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial. J Psychiatr Res 52:1–6. https://doi.org/10.1016/j.jpsychires.2013.11.006

Article  PubMed  Google Scholar 

Gauglitz GG, Bureik D, Dombrowski Y, Pavicic T, Ruzicka T, Schauber J (2012) Botulinum toxin A for the treatment of keloids. Skin Pharmacol Physiol 25:313–318. https://doi.org/10.1159/000342125

Article  CAS  PubMed  Google Scholar 

Gazerani P, Pedersen NS, Staahl C, Drewes AM, Arendt-Nielsen L (2009) Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Pain 141:60–69. https://doi.org/10.1016/j.pain.2008.10.005

Article  CAS  PubMed  Google Scholar 

Gfrerer L, Xu W, Austen W, Ashina S, Melo-Carrillo A, Longhi MS et al (2022) OnabotulinumtoxinA alters inflammatory gene expression and immune cells in chronic headache patients. Brain 145:2436–2449. https://doi.org/10.1093/brain/awab461

Article  PubMed  Google Scholar 

Hajj R, Haddad C (2021) The anti-nociceptive/anti-inflammatory actions of botulinum toxin a for the treatment of chronic pain: a literature review. Current Res Dent 12:62–70. https://doi.org/10.3844/crdsp.2021.62.70

Article  Google Scholar 

Hao R, Li Z, Chen X, Ye W (2018) Efficacy and possible mechanisms of botulinum toxin type A on hypertrophic scarring. J Cosmet Dermatol [internet] 17:340–346. https://doi.org/10.1111/jocd.12534

Article  PubMed  Google Scholar 

Hubbard CS, Becerra L, Smith JH, DeLange JM, Smith RM, Black DF et al (2016) Brain changes in responders vs non-responders in chronic migraine: markers of disease reversal. Front Hum Neurosci. https://doi.org/10.3389/fnhum.2016.00497

Article  PubMed  PubMed Central  Google Scholar 

Ines Novo Pereira, Sara Durão, Giancarlo De la Torre Canales, Ana Cristina Braga, André Mariz Almeida, Haidar Hassan, et al. Biomarkers in Preclinical Research on Botulinum Toxin effects on Inflammation-associated Chronic Conditions. PROSPERO 2023 CRD42023432411 [Internet]. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023432411

Ines Novo Pereira, Sara Durão, Haidar Hassan, Ana Cristina Braga, André Mariz Almeida, Ana Cristina Manso, et al. Biomarkers in clinical research on botulinum toxin effects on inflammation-associated chronic conditions. PROSPERO 2023 CRD2023432131 [Internet]. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023432131

Jeong HS, Lee BH, Sung HM, Park SY, Ahn DK, Jung MS et al (2015) Effect of botulinum toxin type A on differentiation of fibroblasts derived from scar tissue. Plast Reconstr Surg. https://doi.org/10.1097/PRS.0000000000001438

Article  PubMed